A detailed history of Amh Equity LTD transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Amh Equity LTD holds 99,205 shares of CLGN stock, worth $338,289. This represents 0.68% of its overall portfolio holdings.

Number of Shares
99,205
Previous 75,647 31.14%
Holding current value
$338,289
Previous $375,000 31.47%
% of portfolio
0.68%
Previous 0.52%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$4.28 - $5.45 $100,828 - $128,391
23,558 Added 31.14%
99,205 $493,000
Q2 2024

Aug 06, 2024

BUY
$4.84 - $6.75 $366,131 - $510,617
75,647 New
75,647 $375,000

Others Institutions Holding CLGN

About CollPlant Biotechnologies Ltd


  • Ticker CLGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,086,500
  • Market Cap $37.8M
  • Description
  • CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...
More about CLGN
Track This Portfolio

Track Amh Equity LTD Portfolio

Follow Amh Equity LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amh Equity LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amh Equity LTD with notifications on news.